THE CALORIGENIC ACTION OF THYROID SUBSTANCE IN OBESE PATIENTS
| Autor: | Murray B. Gordon, Milton B. Handelsman |
|---|---|
| Rok vydání: | 1941 |
| Předmět: |
medicine.medical_specialty
Thyroid therapy business.industry Endocrinology Diabetes and Metabolism Biochemistry (medical) Clinical Biochemistry Thyroid medicine.disease Biochemistry Obesity Childhood obesity Endocrinology medicine.anatomical_structure Normal weight Weight loss Internal medicine Medicine Underweight medicine.symptom business Confusion |
| Zdroj: | The Journal of Clinical Endocrinology & Metabolism. 1:612-619 |
| ISSN: | 1945-7197 0021-972X |
| DOI: | 10.1210/jcem-1-7-612 |
| Popis: | IN THE TREATMENT of obesity much confusion exists concerning the use of thyroid substance. This was originally created by Von Noorden (1) who claimed that obesity was due to thyroid deficiency and assumed a substitutional value to thyroid therapy. Many studies have since shown that hypothy-roidism is only a relatively small factor in the devel’ opment of obesity. In fact, myxedematous patients who are thin or of normal weight are not infrequent, and cases described as non-myxederoatous hypothy-roidism are usually underweight (2). Gordon (3) in a study of obesity in childhood, found only 6% that he classified as primary hypothryoidism. Lyon and Dunlop (4) also found a small number among obese adults. Spriggs (5)found only 15% of his obese patients with B.M.R.'s lower than normal. Obesity is no longer considered due to hypothryoidism alone and thyroid therapy cannot be considered substitutional treatment in all cases. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|